EAM Investors LLC Sells 4,964 Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS)

EAM Investors LLC cut its holdings in Sensus Healthcare, Inc. (NASDAQ:SRTS) by 5.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 92,103 shares of the company’s stock after selling 4,964 shares during the period. EAM Investors LLC owned 0.56% of Sensus Healthcare worth $637,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in SRTS. IFP Advisors Inc bought a new stake in Sensus Healthcare in the 4th quarter valued at $95,000. Geode Capital Management LLC lifted its stake in shares of Sensus Healthcare by 8.5% in the third quarter. Geode Capital Management LLC now owns 146,404 shares of the company’s stock valued at $849,000 after buying an additional 11,525 shares during the period. Virtu Financial LLC acquired a new stake in Sensus Healthcare during the fourth quarter worth about $189,000. Arrowstreet Capital Limited Partnership increased its stake in Sensus Healthcare by 81.2% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 150,150 shares of the company’s stock valued at $1,039,000 after acquiring an additional 67,269 shares during the period. Finally, XTX Topco Ltd raised its holdings in Sensus Healthcare by 76.0% in the 3rd quarter. XTX Topco Ltd now owns 31,530 shares of the company’s stock valued at $183,000 after acquiring an additional 13,619 shares in the last quarter. Institutional investors and hedge funds own 25.30% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on SRTS shares. Lake Street Capital lowered their price objective on Sensus Healthcare from $18.00 to $13.00 and set a “buy” rating on the stock in a research report on Tuesday, March 11th. HC Wainwright restated a “buy” rating and issued a $12.00 price objective on shares of Sensus Healthcare in a research note on Friday, April 4th.

Sensus Healthcare Stock Performance

Shares of NASDAQ:SRTS opened at $4.59 on Friday. The company has a market capitalization of $75.71 million, a PE ratio of 11.48 and a beta of 1.11. The company’s fifty day moving average is $4.85 and its 200-day moving average is $6.41. Sensus Healthcare, Inc. has a 52 week low of $3.16 and a 52 week high of $9.33.

Sensus Healthcare (NASDAQ:SRTS) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.01). Sensus Healthcare had a return on equity of 12.60% and a net margin of 15.90%. On average, analysts forecast that Sensus Healthcare, Inc. will post 0.32 EPS for the current year.

Sensus Healthcare Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.